ArticleClinical and experimental nephrology2026
Long-term eGFR decline in polycythemia vera compared with secondary polycythemia: a retrospective longitudinal cohort study.
Article in Clinical and experimental nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolycythemia vera (PV) and secondary polycythemia are clinical conditions characterized by erythrocytosis, but their biological basis and clinical course differ. Whether this difference is reflected in long-term kidney function is not well defined. We aimed to compare longitudinal estimated glomerular filtration rate (eGFR) trajectories and kidney function loss in patients with PV and secondary polycythemia.
methodsIn this retrospective, single-center cohort, adult patients with PV or secondary polycythemia were evaluated from baseline through 4 years. Repeated eGFR measurements were examined using a linear mixed-effects model; the group-time interaction was the primary inferential test, with adjustment for age, sex, diabetes mellitus, hypertension, coronary artery disease, and baseline chronic kidney disease.
resultsThe cohort included 1,616 patients: 258 with PV and 1,358 with secondary polycythemia. The global group-time interaction indicated different eGFR trajectories (p = 0.049). The adjusted PV-secondary polycythemia eGFR contrast was small at baseline but indicated lower eGFR in PV by the fourth year (- 3.86 mL/min/1.73 m²; 95% CI, - 6.39 to - 1.33; Holm-corrected p = 0.014). The fourth-year contrast remained in the same direction in most sensitivity analyses.
conclusionPV was associated with a late and modest eGFR separation compared with secondary polycythemia. These findings support consideration of kidney function monitoring in selected patients with PV and prospective assessment of factors influencing renal progression.
Indexed as
Identifiers
42837069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.